Press Releases

Zenas BioPharma Fecha Acordo de Licenciamento e Colaboração Estratégica com a Bristol Myers Squibb para Desenvolvimento e Comercialização do Novo Anticorpo Bifuncional Obexelimab no Japão, Coreia do Sul, Taiwan, Cingapura, Hong Kong e Austrália

Colaboração promove a visão da Zenas de oferecer medicamentos inovadores baseados em imunologia para pacientes em todo o mundo, aproveitando a experiência de longa data da Bristol Myers Squibb com doenças imunomediadas A Zenas receberá um adiantamento de US$ 50 milhões e um investimento de capital da Bristol Myers Squibb, juntamente com potenciais pagamentos e […]

Read More

Zenas BioPharma annonce un accord de licence et de collaboration stratégique avec Bristol Myers Squibb dans le but de développer et commercialiser le nouvel anticorps bifonctionnel obéxélimab au Japon, en Corée du Sud, à Taïwan, à Singapour, à Hong Kong et en Australie

Cette collaboration renforce la vision de Zenas consistant à apporter des médicaments innovants basés sur l’immunologie aux patients dans le monde entier en s’appuyant sur l’expertise de longue date de Bristol Myers Squibb dans les maladies à médiation immunitaire Zenas recevra un paiement au comptant anticipé de 50 millions de dollars et un placement en actions […]

Read More

Zoom introduces Zoom AI Companion — available at no additional cost with paid Zoom user accounts

New generative AI-powered assistant helps improve collaboration and productivity SAN JOSE, Calif., Sept. 05, 2023 (GLOBE NEWSWIRE) — Today, Zoom Video Communications, Inc. (NASDAQ: ZM) announced that Zoom AI Companion (formerly Zoom IQ), the company’s generative AI digital assistant, is now included at no additional cost for customers with the paid services in their Zoom […]

Read More

Zenas BioPharma Announces Strategic License and Collaboration Agreement with Bristol Myers Squibb to Develop and Commercialize Novel Bi-Functional Antibody Obexelimab in Japan, South Korea, Taiwan, Singapore, Hong Kong and Australia

Collaboration furthers Zenas’ vision to bring innovative immunology-based medicines to patients around the world by leveraging Bristol Myers Squibb’s long-standing expertise in immune-mediated diseases Zenas will receive a $50 million up-front cash payment and an equity investment from Bristol Myers Squibb, along with additional potential milestone-based payments and royalties in the licensed territory WALTHAM, Mass., […]

Read More

Sabin Vaccine Institute Leads Public and Private Sector Fight to Prevent HPV and End Cervical Cancer with Global HPV Consortium Launch in Kuala Lumpur

KUALA LUMPUR, Malaysia, Sept. 05, 2023 (GLOBE NEWSWIRE) — The Global HPV Consortium, a worldwide public and private collaboration focused on accelerating prevention of Human Papillomavirus (HPV) and eliminating cervical cancer, launched today in Kuala Lumpur, Malaysia. The Sabin Vaccine Institute will lead the Consortium as its Secretariat. “We are building a new ecosystem in […]

Read More

AI-Media et Middleman annoncent un partenariat d’insertion publicitaire

BROOKLYN, État de New York, 01 sept. 2023 (GLOBE NEWSWIRE) — AI-Media et Middleman Software, Inc., grand fournisseur de solutions de messagerie SCTE 104 et 35, ont joint leurs forces afin d’offrir aux diffuseurs une puissante solution de messagerie unifiée SCTE 104/35 pour les workflows de production en direct. AdIT : AdIT Live de Middleman Software révolutionne […]

Read More

AI-Media e Middleman Anunciam Parceria de Inclusão de Anúncios

BROOKLYN, N.Y., Sept. 01, 2023 (GLOBE NEWSWIRE) — A AI-Media e a Middleman Software, Inc., fornecedora líder de soluções de mensagens SCTE 104 e 35, uniram forças para oferecer às emissoras uma poderosa solução unificada de mensagens SCTE 104/35 para fluxos de trabalho de produção ao vivo. AdIT: O AdIT Live da Middleman Software revoluciona a […]

Read More

AI-Media and Middleman Announce Ad Insertion Partnership

Middleman and AI-Media Enter New Ad Insertion Partnership BROOKLYN, N.Y., Aug. 31, 2023 (GLOBE NEWSWIRE) — AI-Media, and Middleman Software, Inc., a leading provider of SCTE 104 and 35 messaging solutions, have joined forces to offer broadcasters a powerful, unified SCTE 104/35 messaging solution for live production workflows. AdIT: Middleman Software’s AdIT Live revolutionizes the generation of […]

Read More